Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Any Advanced Solid Tumors”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Early research (Phase 1)Ended earlyNCT01804530
What this trial is testing

Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorTumors of Any Histology With Activating Trk (NTRK) Point or NTRK Fusion MutationsTenosynovial Giant Cell Tumor
Plexxikon 59
Not applicableLooking for participantsNCT06590506
What this trial is testing

High Definition Medicine for Solid Tumors Oncology

Who this might be right for
Metastatic Solid TumorAdvanced Cancer
Centro Nacional de Investigaciones Oncologicas CARLOS III 300
Early research (Phase 1)Study completedNCT00698243
What this trial is testing

Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Any Solid Tumor or Lymphoma
Astellas Pharma Inc 128
Not applicableLooking for participantsNCT07433660
What this trial is testing

WellSpan-THRIVE Cancer QOL Study

Who this might be right for
Cancer (Active Cancer, Meaning Not Being Cancer Free), of Any Stage and Involving Any Treatment/Care Regimen; i.e. Curative, Life-extending, or PalliativeCancer (Solid Tumors)Cancer (With or Without Metastasis)+3 more
WellSpan Health 1,000
Early research (Phase 1)Study completedNCT00259935
What this trial is testing

Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors

Who this might be right for
Lung Cancer, Small Cell
GlaxoSmithKline 107
Early research (Phase 1)Active Not RecruitingNCT04521686
What this trial is testing

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

Who this might be right for
CholangiocarcinomaChondrosarcomaGlioma+1 more
Eli Lilly and Company 200
Early research (Phase 1)Study completedNCT02856425
What this trial is testing

Trial Of Pembrolizumab And Nintedanib

Who this might be right for
Patients With Any Advanced Solid Tumors
Gustave Roussy, Cancer Campus, Grand Paris 196
Testing effectiveness (Phase 2)Active Not RecruitingNCT03157128
What this trial is testing

Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)

Who this might be right for
Non-Small Cell Lung CancerMedullary Thyroid CancerColon Cancer+1 more
Eli Lilly and Company 857
Early research (Phase 1)Study completedNCT00920868
What this trial is testing

XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib

Who this might be right for
Solid TumorMetastatic Colorectal Cancer
Herbert Hurwitz, MD 22
Testing effectiveness (Phase 2)Study completedNCT02447406
What this trial is testing

Phase Ib, Single-arm Study of AZD6094 (Volitinib) in Combination With Docetaxel, in Any Solid Cancer and Sequential Phase II, Single-arm Study of AZD6094 (Volitinib) in Combination With Docetaxel in Advanced Gastric Adenocarcinoma Patients With MET Amplification as a Second Line Treatment

Who this might be right for
Advanced Gastric Adenocarcinoma
Samsung Medical Center 7
Early research (Phase 1)Study completedNCT01039155
What this trial is testing

Azacitidine and Oxaliplatin In Treating Patients With Advanced Cancers Relapsed or Refractory to Any Platinum Therapy

Who this might be right for
Adult Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm
National Cancer Institute (NCI) 41